EU FUNDING OPPORTUNITIES AND PROJECT MANAGEMENT TIPS

Proposals should aim to empower patients to manage their pre-existing conditions. Health management will be addressed holistically, including healthy lifestyle interlinked with disease management, placing the patient in the centre and putting increased emphasis on health education, secondary prevention and self-management of individual conditions, including co-morbidities.

Proposals should address all of the following elements a) personalised guidance to patients based on their profiles and the use of wearable/portable devices and improved individual/healthcare-professional interaction, b) engagement of patients as active members in managing their diseases, in particular addressing chronic diseases, co-morbidities, treatment adherence, rehabilitation, self-diagnostics and self-care and c) decision support systems interoperable and/or maintaining integrity with electronic health records.

Expected impact:

• Improving the participation of the patient in the care process.
• Improving the management of a disease by reducing the number of severe episodes and complications.
• Increasing the level of education and adherence of individuals, patients and care givers related to application of ICT for personalised care.
• Improved interaction between patients, their relatives, providers of health-, social-, and informal care givers.
• Strengthened evidence base on health outcomes, quality of life, care efficiency gains and economic benefits from the use of ICT in new care models.
• Reinforced medical knowledge with respect to efficient management of comorbidities.
• Increased confidence in decision support systems for disease/patient management.
• Involvement of health care providers/authorities with increased commitment in the deployment of innovative services empowering the patient.

Type of action: Pre-commercial procurement co-fund actions.

Scope: Proposals should focus on regenerative medicine therapies which are ready for clinical (in-patient) research. Proposals should have at the time of proposal submission the necessary ethical and regulatory authorisations to carry out the work or provide evidence of regulatory engagement and that such approval is close. Preference will be given to proposals which have or are closest to having approvals in place for clinical work to start. Since the objective is to test new regenerative therapies, proposals may address any disease or condition but a justification for the choice must be provided. Clinical work should represent a central part of the project.       

The Commission considers that proposals requesting a contribution from the EU of between EUR 4 and 6 million would allow this specific challenge to be addressed appropriately. Nonetheless, this does not preclude submission and selection of proposals requesting other amounts.

Deadline: 21.04.2014

The subject matter of the contract is a study to measure the use of ICT and eHealth applications by primary care physicians in the European Union, plus Iceland, Norway and Turkey.

Deadline: 1/12/2015

The European Commission has launched a call for tender for a study to assess the progress of the eHealth Action Plan in every objective. This will steer the preparation and design of the post-2015 programming period.

The evaluation of the eHealth Action Plan 2012-2020 will contribute to the eHealth strategy of DG CONNECT and could support the same exercise by 2020.

The current study should include the assessment of the progress of the e-HAP in every objective by:
1. analysing the added value of having an action plan;
2. providing an overview of the implementation of the e-HAP in the first 2-3 years, including a quantitative and
qualitative description of the priorities set, the financial mechanisms used (e.g. operating grants, joint actions,
tenders, etc.), the beneficiaries reached, the actions funded, and the intended results;
3. assessing the relevance, effectiveness and efficiency of the funded actions, taking into consideration the
fact that the majority of the actions funded will not have provided all the deliverables and final reports when the
evaluation takes place, so the assessment of impact will have to be forward-looking. However, some preliminary
outcome should be analysed, above all related to the data strategy;
4. assessing the impact and adoption of the policy targets.
This assessment should include desk work on the projects and studies supported by the EC, in addition to a
survey with representatives of MSs or other key stakeholders about the progress, impact and added value of
the actions which have taken place. The study should look for quantitative and objective indicators. Satisfaction
surveys should be complementary.

Maximum value 200 000 EUR.

Time limit for receipt of tenders or requests to participate
19.9.2014 - 16:00

Proposals should build on existing initiatives and EU projects in the area. Proposals should ensure sufficient involvement of stakeholders (including at least Member States, Industry and international standards development organisations (SDOs)), consensus building and endorsement of the work carried out and of the submitted deliverables. Contribution to the EU eHealth Interoperability Framework should be demonstrated. The successful proposal should support large scale deployments of eHealth services (including cross border) in Europe and contribute to the implementation of the EU-US MoU and roadmap.

Proposals should investigate the use of SNOMED CT as a core terminology to solve semantic interoperability issues for cross border but also national and regional eHealth deployments in the EU. Proposals should cover aspects such as costs (license or membership, but also operational, translations, mapping to local terminologies, maintenance, training,…), fitness to clinical requirements, legal, technical and operational, benefits, governance, impact on the different stakeholders including patients and healthcare providers, for the cross border as well as for the national and regional scenarios. Proposals should compare the SNOMED scenario with at least two scenarios: a) do nothing at the EU level and b) define a semantic interoperability framework without SNOMED CT. Proposals should assess whether SNOMED CT satisfies the criteria listed in the annex II of the EU standardization regulation. Proposals should take into account advice and guidelines from the eHealth Network but also developments related to the EU-US roadmap.

Deadline:15.04.2014